Stockreport

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing [Yahoo! Finance]

MyMD Pharmaceuticals, Inc.  (MYMD) 
PDF company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions, today announced that it received notice from The Nasdaq [Read more]